{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:17:14Z","timestamp":1786990634547,"version":"build-2736575974"},"reference-count":12,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008730","name":"The Norwegian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ijgc.2025.101915","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T02:33:31Z","timestamp":1746239611000},"page":"101915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic value of tertiary lymphoid structures in molecular subgroups of endometrial carcinoma"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1984-9760","authenticated-orcid":false,"given":"Manohar","family":"Pradhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9639-6868","authenticated-orcid":false,"given":"Wanja","family":"Kildal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljiljana","family":"Vlatkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0624-4124","authenticated-orcid":false,"given":"Kari Anne R.","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2162-0175","authenticated-orcid":false,"given":"Kristina","family":"Lindemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6231-7247","authenticated-orcid":false,"given":"Gunnar B.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8370-5289","authenticated-orcid":false,"given":"Andreas","family":"Kleppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne A.","family":"Askautrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ijgc.2025.101915_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009143","article-title":"Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer","volume":"12","author":"Grau Bejar","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"7791","key":"10.1016\/j.ijgc.2025.101915_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ijgc.2025.101915_bib3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijgc.2025.101915_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fimmu.2016.00407","article-title":"Tertiary lymphoid structures in cancers: prognostic value, regulation, and manipulation for therapeutic intervention","volume":"7","author":"Saut\u00e8s-Fridman","year":"2016","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.101915_bib5","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s41467-022-29040-x","article-title":"Tertiary lymphoid structures critical for prognosis in endometrial cancer patients","volume":"13","author":"Horeweg","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijgc.2025.101915_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.113584","article-title":"Impact of molecular profile on prognosis and relapse pattern in low and intermediate risk endometrial cancer","volume":"200","author":"Lindemann","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijgc.2025.101915_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ygyno.2024.11.005","article-title":"Prognostic and therapeutic implication of molecular classification including L1CAM expression in high-risk endometrial cancer","volume":"192","author":"Kleppe","year":"2025","journal-title":"Gynecol Oncol"},{"issue":"0","key":"10.1016\/j.ijgc.2025.101915_bib8","article-title":"Real-world outcomes in molecular subgroups for patients with advanced or recurrent endometrial cancer treated with platinum-based chemotherapy","volume":"0","author":"Lindemann","year":"2024","journal-title":"Int J Gynecol Cancer"},{"issue":"13","key":"10.1016\/j.ijgc.2025.101915_bib9","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/jnci\/djm024","article-title":"Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials","volume":"99","author":"Punt","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"6576","key":"10.1016\/j.ijgc.2025.101915_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ijgc.2025.101915_bib11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/PGP.0000000000001027","article-title":"Characteristics and significance of tertiary lymphoid structures based on molecular subtypes in endometrial cancer","volume":"43","author":"Jia","year":"2024","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"10.1016\/j.ijgc.2025.101915_bib12","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00262-021-03093-1","article-title":"Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer","volume":"71","author":"Qin","year":"2022","journal-title":"Cancer Immunol Immunother"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25010357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25010357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T22:50:40Z","timestamp":1747954240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X25010357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1048891X25010357"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.101915","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of tertiary lymphoid structures in molecular subgroups of endometrial carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.101915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of European Society of Gynaecological Oncology and the International Gynecologic Cancer Society.","name":"copyright","label":"Copyright"}],"article-number":"101915"}}